Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Accord Healthcare Inc. with status Current. The shortage was first posted on Apr 28, 2023. Reported reason: Discontinuation of the manufacture of the drug
Shortage details
- Status
- Current
- Company
- Accord Healthcare Inc.
- Package NDC
- 16729-295-33
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)
- Initial Posting
- Apr 28, 2023
Reason
Discontinuation of the manufacture of the drug